Spots Global Cancer Trial Database for pazopanib and paclitaxel
Every month we try and update this database with for pazopanib and paclitaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma | NCT01107665 | Stage III Melan... Stage IV Melano... Unresectable Me... | Pazopanib and P... | 18 Years - | University of California, Irvine | |
[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer | NCT01608009 | Ovarian Neoplas... | Pazopanib and p... | 18 Years - | Imperial College London |